Hwa An Medical Obtains U.S. Patent for Diabetic Ulcer Treatment Method
Hwa An Medical has successfully obtained a U.S. national phase patent for its method of treating dia… · 2026-08-10
華安 News Releases
Hwa An Announces Signing of Collaborative Development Agreement with Taiwan Tanabe Seiyaku Co., Ltd., Subsidiary of Tanabe Mitsubishi Pharma
Hwa An has signed a collaborative development agreement with Taiwan Tanabe Seiyaku Co., Ltd. to join… · 2026-08-06
Hwa An Announces FDA Clinical Hold on Phase II Trial Application for Parkinson's Drug ENERGI-F705PD
Hwa An's investigational oral drug ENERGI-F705PD for Parkinson's disease has received a clinical hol… · 2026-07-27
Hwa An Announces Signing of Technology and Patent Application Rights Assignment Agreement with Subsidiary Yuan Hwa SmartMed Co., Ltd.
Hwa An has signed an agreement to assign proprietary technology and patent application rights for vi… · 2026-07-08
Hwa An Announces IND Submission to FDA for Phase II Clinical Trial of Parkinson's Oral Drug ENERGI-F705PD
Hwa An has announced the submission of an Investigational New Drug (IND) application to the U.S. FDA… · 2026-06-26
[Waan] February 2026 Revenue: NT$0.00 Billion (YoY -8.5%)
Waan Medical announced its financial data for February 2026, with a monthly revenue of NT$270,000 (a… · 2026-02-01
Hwa An Reports May 2026 Revenue of NT$0.01 Billion (YoY -24.1%)
Hwa An (stock code: 6657), a biotechnology and healthcare company, announced its revenue for May 202… · 2026-05-01
[Hua An] Company Invited to Attend Investor Conference Hosted by Grand Cathay Securities
Hua An Company has been invited to participate in an investor conference hosted by Grand Cathay Secu… · 2026-06-11
[Huaan] Announcement of Important Resolutions from the Annual General Meeting
Huaan held its Annual General Meeting on May 22, approving the 114th fiscal year financial statement… · 2026-05-22
Huaan: March 2026 Revenue Reaches 0.01 Billion Yuan (Up 50.2% Year-on-Year)
Huaan reported March 2026 revenue of 0.01 billion yuan, a significant 50.2% increase year-on-year. T… · 2026-03-01
[HUA AN] April 2026 Revenue: 0.01 Billion TWD (YoY +89.9%)
HUA AN announced April 2026 revenue of 0.01 billion TWD, a significant 89.9% increase year-over-year… · 2026-04-01
Formosa Biomedical Technology Corp. Announces Board Approval of Q1 2026 Financial Report
Formosa Biomedical Technology Corp. (華安) announced that its Board of Directors approved the Q1 2026 … · 2026-05-08
Hua An Announces Date for Board Meeting to Review Q1 2026 Financial Report
Hua An announced that its board of directors meeting to review the Q1 2026 financial report will be … · 2026-04-30
Huaan: March 2026 Revenue Reaches 0.01 Billion Yuan (Up 50.2% Year-on-Year)
Huaan reported March 2026 revenue of 0.01 billion yuan, a significant 50.2% increase year-on-year. T… · 2026-03-01
[Waan] February 2026 Revenue: NT$0.00 Billion (YoY -8.5%)
Waan Medical announced its financial data for February 2026, with a monthly revenue of NT$270,000 (a… · 2026-02-01
[HUA AN] April 2026 Revenue: 0.01 Billion TWD (YoY +89.9%)
HUA AN announced April 2026 revenue of 0.01 billion TWD, a significant 89.9% increase year-over-year… · 2026-04-01
Hua An Announces Date for Board Meeting to Review Q1 2026 Financial Report
Hua An announced that its board of directors meeting to review the Q1 2026 financial report will be … · 2026-04-30
Formosa Biomedical Technology Corp. Announces Board Approval of Q1 2026 Financial Report
Formosa Biomedical Technology Corp. (華安) announced that its Board of Directors approved the Q1 2026 … · 2026-05-08